Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.
Zelluna Immunotherapy has raised $6.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Zelluna Immunotherapy's investors include Takeda Ventures, Birk Venture.
Zelluna Immunotherapy is headquartered in Oslo, Norway.
Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.
Zelluna Immunotherapy is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zelluna Immunotherapy — Funding & Investors." VCBacked, June 17, 2026, https://www.vcbacked.co/company/zelluna-immunotherapy. Accessed August 14, 2026.
VCBacked. (2026). Zelluna Immunotherapy — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/zelluna-immunotherapy
{{cite web |title=Zelluna Immunotherapy — Funding & Investors |url=https://www.vcbacked.co/company/zelluna-immunotherapy |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated